Literature DB >> 9162304

The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics.

A Schatzkin1, E Lanza, L S Freedman, J Tangrea, M R Cooper, J R Marshall, P A Murphy, J V Selby, M Shike, R R Schade, R W Burt, J W Kikendall, J Cahill.   

Abstract

The Polyp Prevention Trial (PPT) is a multicenter randomized controlled trial examining the effect of a low-fat (20% of total energy intake), high-fiber (18 g/1000 kcal), high-vegetable and -fruit (5-8 daily servings) dietary pattern on the recurrence of adenomatous polyps of the large bowel, precursors of most colorectal malignancies. Eligibility criteria include one or more adenomas removed within 6 months of randomization; complete nonsurgical polyp removal and complete colonic examination to the cecum at the qualifying colonoscopy: age 35 years of more; no history of colorectal cancer, inflammatory bowel disease, or large bowel resection; and satisfactory completion of a food frequency questionnaire and 4-day food record. Of approximately 38,277 potential participants with one or more polyps recently resected, investigators at eight clinical centers randomized 2,079 (5.4%; 1,037 in the intervention and 1,042 in the control arm) between June 1991 and January 1994, making the PPT the largest adenoma recurrence trial ever conducted. Of PPT participants, 35% are women and 10% are minorities. At study entry, participants averaged 61.4 years of age; 14% of them smoked, and 22% used aspirin. At the baseline colonoscopy, 35% of participants had two or more adenomas, and 29% had at least one large (> of = 1 cm) adenoma. Demographic, behavioral, dietary, and clinical characteristics are comparable across the two study arms. Participants have repeat colonoscopies after 1 (T(1)) and 4 (T(4)) years of follow-up. The primary end point is adenoma recurrence; secondary end points include number, size, location, and histology of adenomas. All resected lesions are reviewed centrally by gastrointestinal pathologists. The trial provides 90% power to detect a reduction of 24% in the annual adenoma recurrence rate. The primary analytic period, on which sample size calculations were based is 3 years (T(1) to T(4)), which permits a 1-year lag time for the intervention to work and allows a more definitive clearing of lesions at T(1), given that at least 10-15% of polyps may be missed at baseline. The final (T(4)) colonoscopies are expected to be completed in early 1998.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9162304

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  24 in total

1.  Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15): a potential screening tool for the prevention of colon cancer?

Authors:  David A Brown; Kenneth W Hance; Connie J Rogers; Leah B Sansbury; Paul S Albert; Gwen Murphy; Adeyinka O Laiyemo; Zhuoqiao Wang; Amanda J Cross; Arthur Schatzkin; Mark Danta; Preeyaporn Srasuebkul; Janaki Amin; Matthew Law; Samuel N Breit; Elaine Lanza
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-12-05       Impact factor: 4.254

Review 2.  Reduced or modified dietary fat for preventing cardiovascular disease.

Authors:  Lee Hooper; Carolyn D Summerbell; Rachel Thompson; Deirdre Sills; Felicia G Roberts; Helen J Moore; George Davey Smith
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

3.  Authors' response to Eluri et al. letter to the editor regarding: Colorectal cancer prevention by an optimized colonoscopy protocol in routine practice.

Authors:  Sudha Xirasagar; Piet C de Groen
Journal:  Int J Cancer       Date:  2015-02-24       Impact factor: 7.396

Review 4.  Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas.

Authors:  Yibo Yao; Tao Suo; Roland Andersson; Yongqing Cao; Chen Wang; Jingen Lu; Evelyne Chui
Journal:  Cochrane Database Syst Rev       Date:  2017-01-08

5.  High dry bean intake and reduced risk of advanced colorectal adenoma recurrence among participants in the polyp prevention trial.

Authors:  Elaine Lanza; Terryl J Hartman; Paul S Albert; Rusty Shields; Martha Slattery; Bette Caan; Electra Paskett; Frank Iber; James Walter Kikendall; Peter Lance; Cassandra Daston; Arthur Schatzkin
Journal:  J Nutr       Date:  2006-07       Impact factor: 4.798

6.  Colorectal cancer prevention by a CLEAR principles-based colonoscopy protocol: an observational study.

Authors:  Sudha Xirasagar; Yuqi Wu; Meng-Han Tsai; Jiajia Zhang; Stephanie Chiodini; Piet C de Groen
Journal:  Gastrointest Endosc       Date:  2019-12-07       Impact factor: 9.427

7.  Factors associated with the risk of adenoma recurrence in distal and proximal colon.

Authors:  Adeyinka O Laiyemo; Chyke Doubeni; Paul F Pinsky; V Paul Doria-Rose; Pamela M Marcus; Robert E Schoen; Elaine Lanza; Amanda J Cross
Journal:  Digestion       Date:  2013-03-15       Impact factor: 3.216

8.  Chemopreventive effect of nonsteroidal anti-inflammatory drugs on the development of a new colorectal polyp or adenoma in a high-risk population: a meta-analysis.

Authors:  Emine Arzu Kanik; Hakan Canbaz; Tahsin Colak; Suha Aydin
Journal:  Curr Ther Res Clin Exp       Date:  2004-07

Review 9.  Dietary lifestyle and colorectal cancer onset, recurrence, and survival: myth or reality?

Authors:  Katia Lofano; Mariabeatrice Principi; Maria Principia Scavo; Maria Pricci; Enzo Ierardi; Alfredo Di Leo
Journal:  J Gastrointest Cancer       Date:  2013-03

10.  Short- and long-term risk of colorectal adenoma recurrence among whites and blacks.

Authors:  Adeyinka O Laiyemo; Chyke Doubeni; Hassan Brim; Hassan Ashktorab; Robert E Schoen; Samir Gupta; Aline Charabaty; Elaine Lanza; Duane T Smoot; Elizabeth Platz; Amanda J Cross
Journal:  Gastrointest Endosc       Date:  2013-01-18       Impact factor: 9.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.